Evidence map›Paper›PMID 39694623›Full record

Trial reportBMJ global health2024

Cost-effectiveness of integrating paediatric tuberculosis services into child healthcare services in Africa: a modelling analysis of a cluster-randomised trial.

Nyashadzaishe Mafirakureva, Lise Denoeud-Ndam, Boris Kevin Tchounga, Rose Otieno-Masaba, Nicole Herrera, Sushant Mukherjee, Martina Casenghi, Appolinaire Tiam, Peter J Dodd, INPUT study group

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ global health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nyashadzaishe MafirakurevaDivision of Population Health, The University of Sheffield, Sheffield, UK n.mafirakureva@sheffield.ac.uk.ORCID http://orcid.org/0000-0001-9775-6581
Lise Denoeud-NdamElizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-9482-1461
Boris Kevin TchoungaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Yaoundé, Cameroon.ORCID http://orcid.org/0000-0002-8747-9610
Rose Otieno-MasabaResearch, Elizabeth Glaser Pediatric AIDS Foundation, Nairobi, Kenya.
Nicole HerreraElizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Sushant MukherjeeElizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Martina CasenghiInnovation and New Technology, Elizabeth Glaser Pediatric AIDS Foundation, Geneva, Switzerland.ORCID http://orcid.org/0000-0002-7295-3076
Appolinaire TiamElizabeth Glaser Pediatric AIDS Foundation, Washington, District of Columbia, USA.
Peter J DoddDivision of Population Health, The University of Sheffield, Sheffield, UK.ORCID http://orcid.org/0000-0001-5825-9347
INPUT study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn 2021, over one million children developed tuberculosis, resulting in 214 000 deaths, largely due to inadequate diagnosis and treatment. The diagnosis and treatment of tuberculosis is limited in most high-burden countries because services are highly centralised at secondary/tertiary levels and are managed in a vertical, non-integrated way. To improve case detection and treatment among children, the World Health Organisation (WHO) recommends decentralised and integrated tuberculosis care models. The Integrating Paediatric TB Services Into Child Healthcare Services in Africa (INPUT) stepped-wedge cluster-randomised trial evaluated the impact of integrating tuberculosis services into healthcare for children under five in Cameroon and Kenya, compared with usual care, finding a 10-fold increase in tuberculosis case detection in Cameroon but no effect in Kenya.

methodsWe estimated intervention impact on healthcare outcomes, resource use, health system costs and cost-effectiveness relative to the standard of care (SoC) using a decision tree analytical approach and data from the INPUT trial. INPUT trial data on cascades, resource use and intervention diagnostic rate ratios were used to parametrise the decision tree model. Health outcomes following tuberculosis treatment were modelled in terms of mortality and disability-adjusted life-years (DALYs).

findingsFor every 100 children starting antituberculosis treatment under SoC, an additional 876 (95% uncertainty interval (UI) -76 to 5518) in Cameroon and -6 (95% UI -61 to 96) in Kenya would start treatment under the intervention. Treatment success would increase by 5% in Cameroon and 9% in Kenya under the intervention compared with SoC. An estimated 350 (95% UI -31 to 2204) and 3 (95% UI -22 to 48) deaths would be prevented in Cameroon and Kenya, respectively. The incremental cost-effectiveness ratio for the intervention compared with SoC was US$506 and US$1299 per DALY averted in Cameroon and Kenya, respectively.

interpretationAlthough likely to be effective, the cost-effectiveness of integrating tuberculosis services into child healthcare services depends on baseline service coverage, tuberculosis detection and treatment outcomes.

Indexed as

Child Health ServicesCost-Benefit AnalysisTuberculosisCameroonChild, PreschoolCluster AnalysisDelivery of Health Care, IntegratedFemaleHumansInfantKenyaMaleQuality-Adjusted Life YearsHealth economicsMathematical modellingPaediatricsTreatmentTuberculosis

Identifiers

PMID39694623
PMCPMC11667313

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.